Fig. 1.
![Fig. 1. Actuarial survival from relapse according to prognostic features. / (A) Donor type (SIB, HLA-identical sibling; VUD, volunteer unrelated donor); (B) interval from diagnosis to transplant; (C) disease phase at transplant (CP, chronic phase); (D) time to relapse; (E) disease stage at relapse (CYT, cytogenetic relapse; HCP, hematologic relapse in chronic phase; HAP, hematologic relapse in advanced phase [ie, accelerated phase or blastic phase]).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/95/11/10.1182_blood.v95.11.3328/6/bloo01128001x.jpeg?Expires=1735569634&Signature=oLmMbcsJaB4ju91OfoFjbK4ZI6oxz2FXvxnzdXrHuBjVU672hTOjicDR7g6dGHc4nIthvfy48mu91KP8nYEG0n~qkKsKRzsJDl2rQFyr0gFxutpVpPNVxJVnTYdAFTl~9YwWF3RGaL4RdHxgatyuCyfF2SQuSG6JA6VyN0MrfCZ3hnC62mJtji8J4wDL5Ed-6Kn5e1PWgMQR8cj34hhCt2BQ1hpe3VQo4yKtyDJVF50JsJ3~QptfWeGu6Y1LfuofVH0X65~KVb~red394sMIMrKFXqXln4KUSpbeyB6WuZd7LEWNHCjwMd4pPFnxLvpFOn07creIzhXGj427bIk1Ig__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Actuarial survival from relapse according to prognostic features.
(A) Donor type (SIB, HLA-identical sibling; VUD, volunteer unrelated donor); (B) interval from diagnosis to transplant; (C) disease phase at transplant (CP, chronic phase); (D) time to relapse; (E) disease stage at relapse (CYT, cytogenetic relapse; HCP, hematologic relapse in chronic phase; HAP, hematologic relapse in advanced phase [ie, accelerated phase or blastic phase]).
